Literature DB >> 1457212

Differential tropism of clinical HIV-1 isolates for primary monocytes and promonocytic cell lines.

H Schuitemaker1, N A Kootstra, M Groenink, R E De Goede, F Miedema, M Tersmette.   

Abstract

Previously we demonstrated a correlation between a nonsyncytium-inducing (NSI), non-T-cell line tropic phenotype of HIV-1 isolates and the capacity to replicate in primary monocyte-derived macrophages (MDM). Here we demonstrate that these NSI, monocytotropic HIV-1 isolates lack the capacity to replicate in two promonocytic cell-lines, HL60 and U937. In contrast, most syncytium-inducing (SI) HIV-1 isolates with tropism for T-cell lines and generally non-monocytotropic were able to establish a productive infection in promonocytic cell lines. Similar differences in tropism for monocytes and promonocytic cell lines were observed with infectious molecular clones. Our results indicate that virological studies on promonocytic cell lines do not necessarily pertain to the HIV-1 infection of monocytes in vivo.

Entities:  

Mesh:

Year:  1992        PMID: 1457212     DOI: 10.1089/aid.1992.8.1679

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  10 in total

1.  Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline.

Authors:  R B Markham; W C Wang; A E Weisstein; Z Wang; A Munoz; A Templeton; J Margolick; D Vlahov; T Quinn; H Farzadegan; X F Yu
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

2.  Standardized microtiter assay for determination of syncytium-inducing phenotypes of clinical human immunodeficiency virus type 1 isolates.

Authors:  A J Japour; S A Fiscus; J M Arduino; D L Mayers; P S Reichelderfer; D R Kuritzkes
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

3.  Expanded tropism of primary human immunodeficiency virus type 1 R5 strains to CD4(+) T-cell lines determined by the capacity to exploit low concentrations of CCR5.

Authors:  N Dejucq; G Simmons; P R Clapham
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

4.  1,25-Dihydroxyvitamin D3 upregulates functional CXCR4 human immunodeficiency virus type 1 coreceptors in U937 minus clones: NF-kappaB-independent enhancement of viral replication.

Authors:  P Biswas; M Mengozzi; B Mantelli; F Delfanti; A Brambilla; E Vicenzi; G Poli
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

5.  The cell tropism of human immunodeficiency virus type 1 determines the kinetics of plasma viremia in SCID mice reconstituted with human peripheral blood leukocytes.

Authors:  G R Picchio; R J Gulizia; K Wehrly; B Chesebro; D E Mosier
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

6.  Differentiation of promonocytic U937 subclones into macrophagelike phenotypes regulates a cellular factor(s) which modulates fusion/entry of macrophagetropic human immunodeficiency virus type 1.

Authors:  H Moriuchi; M Moriuchi; A S Fauci
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

7.  The selection of low envelope glycoprotein reactivity to soluble CD4 and cold during simian-human immunodeficiency virus infection of rhesus macaques.

Authors:  Kathleen McGee; Hillel Haim; Birgit Korioth-Schmitz; Nicole Espy; Hassan Javanbakht; Norman Letvin; Joseph Sodroski
Journal:  J Virol       Date:  2013-10-16       Impact factor: 5.103

Review 8.  Mechanisms for Cell-to-Cell Transmission of HIV-1.

Authors:  Lucie Bracq; Maorong Xie; Serge Benichou; Jérôme Bouchet
Journal:  Front Immunol       Date:  2018-02-19       Impact factor: 7.561

9.  Quantitative GPCR and ion channel transcriptomics in primary alveolar macrophages and macrophage surrogates.

Authors:  Paul J Groot-Kormelink; Lindsay Fawcett; Paul D Wright; Martin Gosling; Toby C Kent
Journal:  BMC Immunol       Date:  2012-10-26       Impact factor: 3.615

10.  Activation of human monocytes after infection by human coronavirus 229E.

Authors:  Marc Desforges; Tina C Miletti; Mylène Gagnon; Pierre J Talbot
Journal:  Virus Res       Date:  2007-07-31       Impact factor: 3.303

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.